FENC Fennec Pharmaceuticals Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: FENC

Price (delayed)

$10.51

Market cap

$368.56M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.11

Enterprise value

$327.31M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 49
Highlights
FENC's debt has dropped by 100% year-on-year
The gross profit has soared by 85% YoY and by 18% from the previous quarter
The quick ratio has contracted by 18% from the previous quarter but it has grown by 15% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://www.fennecpharma.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of FENC

FENC stock price

How has the Fennec Pharmaceuticals stock price performed over time
Intraday
-4.54%
1 week
-0.38%
1 month
-6.91%
1 year
23.79%
YTD
36.49%
QTD
-2.23%

Financial performance

How have Fennec Pharmaceuticals's revenue and profit performed over time
Revenue
$59.22M
Gross profit
$55.51M
Operating income
-$1.13M
Net income
-$3.25M
Gross margin
93.7%
Net margin
-5.5%
Fennec Pharmaceuticals's operating margin has soared by 93% YoY and by 83% from the previous quarter
The operating income has soared by 88% YoY and by 80% QoQ
The gross profit has soared by 85% YoY and by 18% from the previous quarter
FENC's net margin has surged by 85% year-on-year and by 66% since the previous quarter

Price vs fundamentals

How does FENC's price correlate with its fundamentals

Growth

What is Fennec Pharmaceuticals's growth rate over time

Valuation

What is Fennec Pharmaceuticals stock price valuation
P/E
N/A
P/B
8.6
P/S
6.13
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.53
The company's EPS has surged by 75% YoY and by 61% QoQ
The equity has grown by 13% from the previous quarter
The P/S is 94% lower than the 5-year quarterly average of 111.9 but 17% higher than the last 4 quarters average of 5.5
FENC's revenue has soared by 78% YoY and by 16% from the previous quarter

Efficiency

How efficient is Fennec Pharmaceuticals business performance
The company's return on sales has surged by 85% YoY and by 72% QoQ
The return on assets has surged by 80% year-on-year and by 65% since the previous quarter
The ROE has soared by 79% from the previous quarter
The return on invested capital has surged by 65% year-on-year and by 63% since the previous quarter

Dividends

What is FENC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for FENC.

Financial health

How did Fennec Pharmaceuticals financials performed over time
The total assets is 127% more than the total liabilities
The total assets has soared by 69% YoY and by 5% from the previous quarter
Fennec Pharmaceuticals's total liabilities has decreased by 36% YoY and by 2.4% from the previous quarter
FENC's debt is 100% smaller than its equity
The company's debt to equity has surged by 100% YoY
FENC's debt has dropped by 100% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.